{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:29:54Z","timestamp":1790980194086,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"VolkswagenStiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.parkreldis.2021.06.011","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T11:01:54Z","timestamp":1624446114000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria"],"prefix":"10.1016","volume":"89","author":[{"given":"Tina","family":"Mainka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Frederik","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Huebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Mosejova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Skorvanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Freisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Ziagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Ganos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.06.011_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jimd.12065","article-title":"The neurological and psychological phenotype of adult patients with early-treated phenylketonuria: a systematic review","volume":"42","author":"Burlina","year":"2019","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib4","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1212\/WNL.0000000000011088","article-title":"Phenylalanine effects on brain function in adult phenylketonuria","volume":"96","author":"Pilotto","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004310050945","article-title":"Neurological outcome in adult patients with early-treated phenylketonuria","volume":"157","author":"Pietz","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib7","first-page":"531","article-title":"Neurological manifestations in adults with phenylketonuria: new cases and review of the literature","volume":"267","author":"Jaulent","year":"2020","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000007895","article-title":"A\u00a0neurological evaluation of adult phenylketonuria in Northern Ireland","volume":"39","author":"McDonnell","year":"1998","journal-title":"Eur. Neurol."},{"issue":"Suppl","key":"10.1016\/j.parkreldis.2021.06.011_bib9","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.ymgme.2011.07.015","article-title":"Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit","volume":"104","author":"Gonz\u00e1lez","year":"2011","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1203\/00006450-197803000-00004","article-title":"Effects of diet and behavior therapy on social and motor behavior of retarded phenylketonuric adults: an experimental analysis","volume":"12","author":"Marholin","year":"1978","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1542\/peds.20.2.290","article-title":"The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)","volume":"20","author":"Paine","year":"1957","journal-title":"Pediatrics"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/08830738060210111401","article-title":"Phenylketonuria in pediatric neurology practice: a series of 146 cases","volume":"21","author":"Yalaz","year":"2006","journal-title":"J.\u00a0Child Neurol."},{"issue":"Pt 4","key":"10.1016\/j.parkreldis.2021.06.011_bib13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/116.4.811","article-title":"Brain MRI changes in phenylketonuria. Associations with dietary status","volume":"116","author":"Thompson","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/mds.20146","article-title":"L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: in\u00a0vivo dopamine transporter and D2 receptor findings","volume":"19","author":"Evans","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib15","first-page":"2446","article-title":"Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism","volume":"261","author":"Rosini","year":"2014","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13554794.2016.1142567","article-title":"Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism","volume":"22","author":"Tufekcioglu","year":"2016","journal-title":"Neurocase"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0140-6736(90)93401-A","article-title":"Neurological deterioration in young adults with phenylketonuria","volume":"336","author":"Thompson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","article-title":"Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study","volume":"121","author":"Bilder","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.euroneuro.2013.05.012","article-title":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/WCO.0000000000000356","article-title":"Tics and Tourette\u02bcs: update on pathophysiology and tic control","volume":"29","author":"Ganos","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib21","first-page":"1","article-title":"Developmental motor profile in preschool children with primary stereotypic movement disorder","author":"Valente","year":"2019","journal-title":"BioMed Research International. 2019"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1362361307070992","article-title":"Tics and Tourette syndrome in autism spectrum disorders","volume":"11","author":"Canitano","year":"2007","journal-title":"Autism"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib23","first-page":"35","article-title":"Parkinsonism in phenylketonuria: a consequence of dopamine depletion?","volume":"20","author":"Velema","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurol.2013.09.012","article-title":"Progressive neuropsychiatric manifestations of phenylketonuria in adulthood","volume":"170","author":"Daelman","year":"2014","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib25","doi-asserted-by":"crossref","first-page":"17008","DOI":"10.1038\/s41598-018-35215-8","article-title":"Atypical postural control can be detected via computer vision analysis in toddlers with autism spectrum disorder","volume":"8","author":"Dawson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10803-015-2621-4","article-title":"Postural control deficits in autism spectrum disorder: the role of sensory integration","volume":"46","author":"Doumas","year":"2016","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yebeh.2018.02.024","article-title":"Clinical and electrophysiological findings in patients with phenylketonuria and epilepsy: reflex features","volume":"82","author":"Yildiz Celik","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1020158631102","article-title":"Phenylketonuria in adulthood: a collaborative study","volume":"25","author":"Koch","year":"2002","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib30","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib31","series-title":"Engineering, and Medicine, Mental Disorders and Disabilities Among Low-Income Children","year":"2015"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1037\/neu0000358","article-title":"Cognitive profile and mental health in adult phenylketonuria: a PKU-COBESO study","volume":"31","author":"Jahja","year":"2017","journal-title":"Neuropsychology"},{"issue":"Suppl","key":"10.1016\/j.parkreldis.2021.06.011_bib33","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.ymgme.2013.08.013","article-title":"Neurocognitive functioning in adults with phenylketonuria: results of a long term study","volume":"110","author":"Weglage","year":"2013","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1037\/0894-4105.19.5.679","article-title":"Executive functioning and speed of processing in phenylketonuria","volume":"19","author":"Channon","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib35","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1017\/S0033291717001398","article-title":"Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria","volume":"47","author":"Boot","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp.71.6.795","article-title":"Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia","volume":"71","author":"Kasim","year":"2001","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.06.011_bib37","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ymgme.2009.10.009","article-title":"Beyond executive function: non-executive cognitive abilities in individuals with PKU","volume":"99","author":"Janzen","year":"2010","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib38","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3390\/nu11112572","article-title":"Untreated PKU patients without intellectual disability: what do they teach us?","volume":"11","author":"van Vliet","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13023-018-0890-7","article-title":"Can untreated PKU patients escape from intellectual disability? A systematic review","volume":"13","author":"van Vliet","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2019-106278","article-title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines","volume":"57","author":"Leuzzi","year":"2020","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jimd.12049","article-title":"Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria","volume":"42","author":"Pilotto","year":"2019","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-010-9253-9","article-title":"High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial","volume":"34","author":"ten Hoedt","year":"2011","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib43","first-page":"712","article-title":"Self-injurious behaviour in movement disorders: systematic review","volume":"91","author":"Fischer","year":"2020","journal-title":"JNNP"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1871527318666190430162724","article-title":"Autism spectrum disorders: the association with inherited metabolic disorders and some trace elements. A retrospective study","volume":"18","author":"El Fotoh","year":"2019","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib45","doi-asserted-by":"crossref","first-page":"102555","DOI":"10.1016\/j.nicl.2020.102555","article-title":"Diffusion kurtosis imaging detects subclinical white matter abnormalities in Phenylketonuria","volume":"29","author":"Hellewell","year":"2021","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00234-009-0574-z","article-title":"Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria","volume":"51","author":"Manara","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF02436009","article-title":"Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients","volume":"18","author":"Leuzzi","year":"1995","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2021.06.011_bib48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1148\/radiology.177.2.2217781","article-title":"Phenylketonuria: MR imaging of the brain with clinical correlation","volume":"177","author":"Pearsen","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2021.06.011_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmhg.2013.03.001","article-title":"Clinicolaboratory profile of phenylketonuria (PKU) in sohag university hospital-upper Egypt","volume":"14","author":"Sadek","year":"2013","journal-title":"Egyptian Journal of Medical Human Genetics"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021002236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021002236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:22:58Z","timestamp":1761178978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021002236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":49,"alternative-id":["S1353802021002236"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.06.011","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}